NDC properties for "TOBI Podhaler Kit, 224" (RxCUI 1374574)
About this data
The tables show NDC propoerties for TOBI Podhaler Kit, 224 with the RxCUI 1374574
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for TOBI Podhaler Kit, 224 (RxCUI 1374574)
| MMSL_CODE | BD26974 |
|---|---|
| NDA | NDA201688 |
| RxCUI | 1374574 |
| SPL_SET_ID | c4b5bb1f-e158-4ac1-9c35-e98a416c743a |
| Prescribable Synonym | TOBI Podhaler 224 Capsule Monthly Pack |
| RXNAV_STR | TOBI Podhaler Kit, 224 |
| RxNorm Name | {224 (tobramycin 28 MG Inhalation Powder [Tobi]) } Pack [TOBI Podhaler Kit] |
| RxNorm Synonym | TOBI Podhaler Kit, 224 |
| RxNorm Synonym | TOBI Podhaler Kit, 4 Weekly Packs, each including 56 capsules (7 Blister Cards of 8 Capsules) |
| Related queries | Interactions (for RxCUI 1374574) |
NDC Properties
NDC Item 00078063011
| NDC 9 | 0078-0630 |
|---|---|
| NDC 10 | 0078-0630-11 |
| NDC Item | 00078063011 |
| Packaging | 4 in 1 BLISTER PACK |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 511513 |
| Imprint code | NVR;AVCI |
| Labeler | Novartis Pharmaceuticals Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2022-07-31 |
| Marketing effective time low | 2013-03-22 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0078-0630 |
NDC Item 00078063035
| NDC 9 | 0078-0630 |
|---|---|
| NDC 10 | 0078-0630-35 |
| NDC Item | 00078063035 |
| Packaging | 224 PACKAGE in 1 BOX, UNIT-DOSE (0078-0630-35) / 56 BLISTER PACK in 1 PACKAGE (0078-0630-56) / 4 CAPSULE in 1 BLISTER PACK (0078-0630-11) |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 511513 |
| Imprint code | NVR;AVCI |
| Labeler | Novartis Pharmaceuticals Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2022-07-31 |
| Marketing effective time low | 2013-03-22 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0078-0630 |
NDC Item 49502034624
| NDC 9 | 49502-346 |
|---|---|
| NDC 10 | 49502-346-24 |
| NDC Item | 49502034624 |
| Packaging | 224 PACKAGE in 1 BOX, UNIT-DOSE (49502-346-24) / 56 BLISTER PACK in 1 PACKAGE / 4 CAPSULE in 1 BLISTER PACK |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 681698 |
| Imprint code | NVR;AVCI |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2023-05-31 |
| Marketing effective time low | 2020-09-24 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 49502-346 |
NDC Item 49502040124
| NDC 9 | 49502-401 |
|---|---|
| NDC 10 | 49502-401-24 |
| NDC Item | 49502040124 |
| Packaging | 224 PACKAGE in 1 BOX, UNIT-DOSE (49502-401-24) / 56 BLISTER PACK in 1 PACKAGE / 4 CAPSULE in 1 BLISTER PACK |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 859659 |
| Imprint code | MYL;TPH |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2026-12-31 |
| Marketing effective time low | 2021-09-01 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 49502-401 |
NDC Item 00078063011
| NDC 9 | 0078-0630 |
|---|---|
| NDC 10 | 0078-0630-11 |
| NDC Item | 00078063011 |
| Packaging | 4 in 1 BLISTER PACK |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 511513 |
| Imprint code | NVR;AVCI |
| Labeler | Novartis Pharmaceuticals Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2022-07-31 |
| Marketing effective time low | 2013-03-22 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0078-0630 |
NDC Item 00078063035
| NDC 9 | 0078-0630 |
|---|---|
| NDC 10 | 0078-0630-35 |
| NDC Item | 00078063035 |
| Packaging | 224 PACKAGE in 1 BOX, UNIT-DOSE (0078-0630-35) / 56 BLISTER PACK in 1 PACKAGE (0078-0630-56) / 4 CAPSULE in 1 BLISTER PACK (0078-0630-11) |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 511513 |
| Imprint code | NVR;AVCI |
| Labeler | Novartis Pharmaceuticals Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2022-07-31 |
| Marketing effective time low | 2013-03-22 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0078-0630 |
NDC Item 49502034624
| NDC 9 | 49502-346 |
|---|---|
| NDC 10 | 49502-346-24 |
| NDC Item | 49502034624 |
| Packaging | 224 PACKAGE in 1 BOX, UNIT-DOSE (49502-346-24) / 56 BLISTER PACK in 1 PACKAGE / 4 CAPSULE in 1 BLISTER PACK |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 681698 |
| Imprint code | NVR;AVCI |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2023-05-31 |
| Marketing effective time low | 2020-09-24 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 49502-346 |
NDC Item 49502040124
| NDC 9 | 49502-401 |
|---|---|
| NDC 10 | 49502-401-24 |
| NDC Item | 49502040124 |
| Packaging | 224 PACKAGE in 1 BOX, UNIT-DOSE (49502-401-24) / 56 BLISTER PACK in 1 PACKAGE / 4 CAPSULE in 1 BLISTER PACK |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 859659 |
| Imprint code | MYL;TPH |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2026-12-31 |
| Marketing effective time low | 2021-09-01 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 49502-401 |
NDC Item 00078063011
| NDC 9 | 0078-0630 |
|---|---|
| NDC 10 | 0078-0630-11 |
| NDC Item | 00078063011 |
| Packaging | 4 in 1 BLISTER PACK |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 511513 |
| Imprint code | NVR;AVCI |
| Labeler | Novartis Pharmaceuticals Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2022-07-31 |
| Marketing effective time low | 2013-03-22 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0078-0630 |
NDC Item 00078063035
| NDC 9 | 0078-0630 |
|---|---|
| NDC 10 | 0078-0630-35 |
| NDC Item | 00078063035 |
| Packaging | 224 PACKAGE in 1 BOX, UNIT-DOSE (0078-0630-35) / 56 BLISTER PACK in 1 PACKAGE (0078-0630-56) / 4 CAPSULE in 1 BLISTER PACK (0078-0630-11) |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 511513 |
| Imprint code | NVR;AVCI |
| Labeler | Novartis Pharmaceuticals Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2022-07-31 |
| Marketing effective time low | 2013-03-22 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0078-0630 |
NDC Item 49502034624
| NDC 9 | 49502-346 |
|---|---|
| NDC 10 | 49502-346-24 |
| NDC Item | 49502034624 |
| Packaging | 224 PACKAGE in 1 BOX, UNIT-DOSE (49502-346-24) / 56 BLISTER PACK in 1 PACKAGE / 4 CAPSULE in 1 BLISTER PACK |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 681698 |
| Imprint code | NVR;AVCI |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2023-05-31 |
| Marketing effective time low | 2020-09-24 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 49502-346 |
NDC Item 49502040124
| NDC 9 | 49502-401 |
|---|---|
| NDC 10 | 49502-401-24 |
| NDC Item | 49502040124 |
| Packaging | 224 PACKAGE in 1 BOX, UNIT-DOSE (49502-401-24) / 56 BLISTER PACK in 1 PACKAGE / 4 CAPSULE in 1 BLISTER PACK |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 859659 |
| Imprint code | MYL;TPH |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2026-12-31 |
| Marketing effective time low | 2021-09-01 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 49502-401 |
NDC Item 00078063011
| NDC 9 | 0078-0630 |
|---|---|
| NDC 10 | 0078-0630-11 |
| NDC Item | 00078063011 |
| Packaging | 4 in 1 BLISTER PACK |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 511513 |
| Imprint code | NVR;AVCI |
| Labeler | Novartis Pharmaceuticals Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2022-07-31 |
| Marketing effective time low | 2013-03-22 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0078-0630 |
NDC Item 00078063035
| NDC 9 | 0078-0630 |
|---|---|
| NDC 10 | 0078-0630-35 |
| NDC Item | 00078063035 |
| Packaging | 224 PACKAGE in 1 BOX, UNIT-DOSE (0078-0630-35) / 56 BLISTER PACK in 1 PACKAGE (0078-0630-56) / 4 CAPSULE in 1 BLISTER PACK (0078-0630-11) |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 511513 |
| Imprint code | NVR;AVCI |
| Labeler | Novartis Pharmaceuticals Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2022-07-31 |
| Marketing effective time low | 2013-03-22 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0078-0630 |
NDC Item 49502034624
| NDC 9 | 49502-346 |
|---|---|
| NDC 10 | 49502-346-24 |
| NDC Item | 49502034624 |
| Packaging | 224 PACKAGE in 1 BOX, UNIT-DOSE (49502-346-24) / 56 BLISTER PACK in 1 PACKAGE / 4 CAPSULE in 1 BLISTER PACK |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 681698 |
| Imprint code | NVR;AVCI |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2023-05-31 |
| Marketing effective time low | 2020-09-24 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 49502-346 |
NDC Item 49502040124
| NDC 9 | 49502-401 |
|---|---|
| NDC 10 | 49502-401-24 |
| NDC Item | 49502040124 |
| Packaging | 224 PACKAGE in 1 BOX, UNIT-DOSE (49502-401-24) / 56 BLISTER PACK in 1 PACKAGE / 4 CAPSULE in 1 BLISTER PACK |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 859659 |
| Imprint code | MYL;TPH |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2026-12-31 |
| Marketing effective time low | 2021-09-01 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 49502-401 |